IGHE and Alzheimer disease: The total serum IgE level is a typical indicator of the severity of AD.99 LF216EV treatment decreased the elevated serum IgE levels in AD, indicating its efficacy as a functional substance capable of promptly alleviating atopic-induced autoimmune abnormalities.